Admission hyperglycaemia is associated with higher mortality in patients with hip fracture

Riccardo Leto1, Didier Desruelles, Jean-Bernard Gillet

  • 1Department of Emergency Medicine, University Hospitals, Catholic University of Leuven, Leuven, Belgium.

Insights

Hyperglycaemia is common in hip-fracture patients. High admission blood sugar levels (aBSL) are linked to increased in-hospital mortality, suggesting aBSL may be a prognostic indicator.

Area of Science:

  • Geriatric Medicine
  • Endocrinology
  • Trauma Surgery

Background:

  • Hyperglycaemia is a frequent condition in patients admitted for hip fractures.
  • The prognostic significance of admission hyperglycaemia in this patient cohort requires further elucidation.

Purpose of the Study:

  • To ascertain the prevalence of hyperglycaemia in hip-fracture patients.
  • To investigate the association between admission hyperglycaemia and patient outcomes, including mortality, ICU admission, and length of hospital stay.

Main Methods:

  • Retrospective analysis of patient records over a 2-year period.
  • Inclusion criteria: primary diagnosis of hip fracture (ICD-9-CM 820.x).
  • Data sourced from an electronic hospital database.

Main Results:

  • 34% of patients exhibited an admission blood sugar level (aBSL) exceeding 140 mg/dl.
  • Elevated aBSL was significantly associated with higher in-hospital mortality (P=0.042).
  • No significant difference in ICU admissions or length of stay was observed based on aBSL thresholds.

Conclusions:

  • Admission hyperglycaemia is prevalent among hip-fracture patients.
  • Elevated aBSL may serve as a prognostic indicator for mortality in hip-fracture patients.
  • This study highlights hyperglycaemia-associated mortality in less severely injured patients not typically admitted to the ICU.
Abstract

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
25
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
35
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
30
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K